查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1590810

胃食道逆流疾病治疗设备市场：按产品类型、手术类型、手术类型、设备类型、剂型、给药途径和最终用户 - 2025-2030 年全球预测

Gastroesophageal Reflux Disease Devices Market by Product Type, Procedure Type, Surgery Type, Device Type, Dosage Form, Route of Administration, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年胃食道逆流治疗设备市场价值为58.5亿美元，预计2024年将达到66.5亿美元，复合年增长率为13.66%，到2030年将达到143.5亿美元，预计将达到1000万美元。

胃食道逆流症 (GERD) 设备市场包括旨在诊断和治疗 GERD 的医疗设备，GERD 是一种胃酸回流到食道，导致胃灼热和胃酸逆流等症状的疾病。这些医疗设备的需求源于由于生活方式改变、肥胖和饮食等因素导致胃食道逆流（GERD）盛行率不断增加。应用范围包括诊断内视镜检查、酸性暴露的 pH 监测、磁性括约肌增强和射频消融，以满足从轻度到重度逆流情况的患者需求。最终使用领域包括医院、门诊手术中心和专科诊所，这些领域对微创解决方案的需求正在增加。关键的成长要素包括内视镜手术的进步、对胃食道逆流症併发症的认识提高以及支持设备采用的医疗保健政策。由于设备准确性和患者舒适度方面的技术创新，以及医疗保健基础设施正在发展的新兴市场的地理扩张，市场机会正在扩大。为了抓住这些机会，公司应该专注于非侵入性诊断和治疗方法的研究和开发、客製化设备设计以及全球采用的策略伙伴关係。然而，先进设备的高成本、严格的监管核准以及药物和生活方式改变等替代治疗方法的可用性可能会限制其市场的广泛使用。创新可以针对开发具有成本效益且患者友好的诊断工具，以及开髮用于胃食道逆流症监测解决方案的人工智慧和机器学习。由于市场竞争激烈，并且公司专注于产品差异化和患者治疗结果，因此公司不断创新并满足医疗保健提供者的需求非常重要。开拓有关 GERD 管理的教育倡议可以提高最终用户的意识、提高市场渗透率并促进整个 GERD 装置领域的成长。

主要市场统计
基准年[2023] 58.5亿美元
预测年份 [2024] 66.5亿美元
预测年份 [2030] 143.5亿美元
复合年增长率（%） 13.66%

市场动态：快速发展的胃食道逆流治疗设备市场的关键市场洞察

胃食道逆流病治疗设备市场正因供需的动态交互作用而转变。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 世界老化人口增加
    • 肥胖人口不断增加，对手术的偏好日益增加
    • 诊断中心和私人诊所的招募人数迅速增加
  • 市场限制因素
    • 质子帮浦阻断剂等替代药物的可用性
  • 市场机会
    • 活性化技术创新力道及新产品推出进场
    • 自我治疗和疾病意识的持续趋势
  • 市场挑战
    • 设备接受度下降，缺乏标准监管核准

波特五力：驾驭胃食道逆流治疗设备市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对胃食道逆流症治疗器械市场的影响

外部宏观环境因素在塑造胃食道逆流疾病治疗设备市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解胃食道逆流症治疗器材市场竞争状况

胃食道逆流治疗设备市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵胃食道逆流治疗设备市场供应商绩效评估

FPNV定位矩阵是评估胃食道逆流治疗市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，描绘胃食道逆流症治疗设备市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对胃食道逆流治疗设备市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界各地人口老化不断加剧
      • 肥胖人口增加和对手术的偏好增加
      • 诊断中心和私人诊所的采用率迅速增加
    • 抑制因素
      • 质子帮浦抑制剂等替代药物的可用性
    • 机会
      • 强而有力的创新并向市场推出新的先进产品
      • 自我药疗和疾病意识的持续趋势
    • 任务
      • 设备接受度下降，缺乏标准监管核准
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章胃食道逆流症治疗设备市场：依产品类型

  • 诊断设备
  • 食道镜和胃照相机
  • 胃底折迭术器械
  • 测压系统
  • PH监测系统
  • 射频消融术装置
  • 括约肌增强装置
  • 治疗设备
  • 超音波外科腔内吻合器

第七章胃食道逆流症治疗设备市场（依手术类型）

  • 诊断程序
  • 胃底折迭术
  • 磁括约肌增强术
  • 射频热消融

第八章依手术类型分類的胃食道逆流治疗设备市场

  • 侵入性的
    • 山猫逆流症管理
    • Medgas超音波外科内视镜吻合器
  • 非侵入性
    • 腔内胃造口术
    • 内视镜折迭系统
    • 埃索菲克斯
    • 有机玻璃聚甲基丙烯酸甲酯微球
    • 史特雷塔

第九章胃食道逆流症治疗设备市场（依设备类型）

  • Bravo 逆流测试系统
  • DigiTrapper回流侦测系统
  • LINX管理系统
  • MUSE-Medigus超音波外科内视镜吻合器
  • 斯特雷塔疗法

第10章胃食道逆流症治疗器材市场（按剂型）

  • 液体
  • 固体的

第十一章胃食道逆流症治疗设备市场：依给药途径

  • 口服
  • 胃肠外的

第十二章胃食道逆流症治疗设备市场：依最终使用者分类

  • 政府
  • 医院
  • 医务工作者

第十三章北美和南美胃食道逆流症治疗器械市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第14章亚太地区胃食道逆流症治疗器材市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十五章欧洲、中东和非洲胃食道逆流症治疗器材市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十六章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争场景分析
  • 战略分析和建议

公司名单

  • Addex Pharmaceuticals Ltd.
  • Aros Pharma ApS
  • AstraZeneca PLC
  • CR Bard, Inc.
  • Eisai Co., Ltd.
  • EndoGastric Solutions, Inc.
  • Frost & Sullivan Inc.
  • Johnson & Johnson Services, Inc.
  • KARL STORZ SE & Co. KG
  • MediGus Ltd.
  • Olympus Corporation
  • PENTAX Europe GmbH
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited
  • The Procter & Gamble Company
Product Code: MRR-925E8149CEF2

The Gastroesophageal Reflux Disease Devices Market was valued at USD 5.85 billion in 2023, expected to reach USD 6.65 billion in 2024, and is projected to grow at a CAGR of 13.66%, to USD 14.35 billion by 2030.

The Gastroesophageal Reflux Disease (GERD) Devices market encompasses a range of medical devices aimed at diagnosing and treating GERD, a condition characterized by the backflow of stomach acid into the esophagus causing symptoms like heartburn and acid reflux. The necessity of these devices lies in the increasing prevalence of GERD, driven by factors such as lifestyle changes, obesity, and dietary habits. Their application extends across diagnostic endoscopy, pH monitoring for acid exposure, magnetic sphincter augmentation, and radiofrequency ablation, addressing patient needs from mild to severe reflux symptoms. End-use segments include hospitals, ambulatory surgical centers, and specialty clinics where the demand for minimally invasive solutions is rising. Key growth factors include advancements in endoscopic procedures, increased awareness of GERD complications, and supportive healthcare policies favoring device adoption. Market opportunities are expanding with technological innovations in device precision and patient comfort, and geographic expansion in emerging markets with rising healthcare infrastructure. To capture these opportunities, companies should focus on R&D in non-invasive diagnostics and treatment methods, customized device designs, and strategic partnerships to widen global outreach. However, the market faces limitations due to high costs of advanced devices, stringent regulatory approvals, and the availability of alternative treatment methods like medication and lifestyle modification, which might inhibit device adoption. Innovation could be directed towards developing cost-effective, patient-friendly diagnostic tools and exploring AI and machine learning for GERD monitoring solutions. The market is competitive with players focusing on product differentiation and patient outcomes, making it crucial for companies to continuously innovate and align with healthcare provider needs. Developing educational initiatives around GERD management could enhance end-user awareness and drive market penetration, fostering overall growth in the GERD devices sector.

KEY MARKET STATISTICS
Base Year [2023] USD 5.85 billion
Estimated Year [2024] USD 6.65 billion
Forecast Year [2030] USD 14.35 billion
CAGR (%) 13.66%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Gastroesophageal Reflux Disease Devices Market

The Gastroesophageal Reflux Disease Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising aging population across the world
    • Growing obese population and their preference for surgeries
    • Surge in adoption among diagnostic centers and private clinics
  • Market Restraints
    • Availability of alternative such as proton pump inhibitors
  • Market Opportunities
    • Robust innovation and launch of new advanced products in the market
    • Ongoing trend of self-medication and awareness of the disease
  • Market Challenges
    • Decreased acceptability of devices an dearth of standard regulatory approval

Porter's Five Forces: A Strategic Tool for Navigating the Gastroesophageal Reflux Disease Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Gastroesophageal Reflux Disease Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Gastroesophageal Reflux Disease Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Gastroesophageal Reflux Disease Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Gastroesophageal Reflux Disease Devices Market

A detailed market share analysis in the Gastroesophageal Reflux Disease Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Gastroesophageal Reflux Disease Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Gastroesophageal Reflux Disease Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Gastroesophageal Reflux Disease Devices Market

A strategic analysis of the Gastroesophageal Reflux Disease Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Gastroesophageal Reflux Disease Devices Market, highlighting leading vendors and their innovative profiles. These include Addex Pharmaceuticals Ltd., Aros Pharma ApS, AstraZeneca PLC, C. R. Bard, Inc., Eisai Co., Ltd., EndoGastric Solutions, Inc., Frost & Sullivan Inc., Johnson & Johnson Services, Inc., KARL STORZ SE & Co. KG, MediGus Ltd., Olympus Corporation, PENTAX Europe GmbH, Pfizer Inc., Takeda Pharmaceutical Company Limited, and The Procter & Gamble Company.

Market Segmentation & Coverage

This research report categorizes the Gastroesophageal Reflux Disease Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Diagnostic Devices, Esophagoscopes & Gastroscopes, Fundoplication Devices, Manometry System, PH Monitoring System, Radiofrequency Ablation Devices, Sphincter Augmentation Devices, Treatment Devices, and Ultrasonic Surgical Endostapler.
  • Based on Procedure Type, market is studied across Diagnostic Procedures, Fundoplication Procedures, Magnetic Sphincter Augmentation, and Radiofrequency Thermal Ablation.
  • Based on Surgery Type, market is studied across Invasive and Non-Invasive. The Invasive is further studied across Linx Reflux Management and Medigus Ultrasonic Surgical Endostapler. The Non-Invasive is further studied across Endocinch Endolumminal Gastroplication, Endoscopic Plicator System, EsophyX, Plexiglas Poly-Methyl-Methacrylate Microspheres, and Stretta.
  • Based on Device Type, market is studied across Bravo Reflux Testing System, Digitrapper reflux testing system, LINX Management System, MUSE -Medigus Ultrasonic Surgical Endostapler, and Stretta Therapy.
  • Based on Dosage Form, market is studied across Liquid and Solid.
  • Based on Route of Administration, market is studied across Oral and Parenteral.
  • Based on End-User, market is studied across Government, Hospitals, and Medical Practitioners.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising aging population across the world
      • 5.1.1.2. Growing obese population and their preference for surgeries
      • 5.1.1.3. Surge in adoption among diagnostic centers and private clinics
    • 5.1.2. Restraints
      • 5.1.2.1. Availability of alternative such as proton pump inhibitors
    • 5.1.3. Opportunities
      • 5.1.3.1. Robust innovation and launch of new advanced products in the market
      • 5.1.3.2. Ongoing trend of self-medication and awareness of the disease
    • 5.1.4. Challenges
      • 5.1.4.1. Decreased acceptability of devices an dearth of standard regulatory approval
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Gastroesophageal Reflux Disease Devices Market, by Product Type

  • 6.1. Introduction
  • 6.2. Diagnostic Devices
  • 6.3. Esophagoscopes & Gastroscopes
  • 6.4. Fundoplication Devices
  • 6.5. Manometry System
  • 6.6. PH Monitoring System
  • 6.7. Radiofrequency Ablation Devices
  • 6.8. Sphincter Augmentation Devices
  • 6.9. Treatment Devices
  • 6.10. Ultrasonic Surgical Endostapler

7. Gastroesophageal Reflux Disease Devices Market, by Procedure Type

  • 7.1. Introduction
  • 7.2. Diagnostic Procedures
  • 7.3. Fundoplication Procedures
  • 7.4. Magnetic Sphincter Augmentation
  • 7.5. Radiofrequency Thermal Ablation

8. Gastroesophageal Reflux Disease Devices Market, by Surgery Type

  • 8.1. Introduction
  • 8.2. Invasive
    • 8.2.1. Linx Reflux Management
    • 8.2.2. Medigus Ultrasonic Surgical Endostapler
  • 8.3. Non-Invasive
    • 8.3.1. Endocinch Endolumminal Gastroplication
    • 8.3.2. Endoscopic Plicator System
    • 8.3.3. EsophyX
    • 8.3.4. Plexiglas Poly-Methyl-Methacrylate Microspheres
    • 8.3.5. Stretta

9. Gastroesophageal Reflux Disease Devices Market, by Device Type

  • 9.1. Introduction
  • 9.2. Bravo Reflux Testing System
  • 9.3. Digitrapper reflux testing system
  • 9.4. LINX Management System
  • 9.5. MUSE -Medigus Ultrasonic Surgical Endostapler
  • 9.6. Stretta Therapy

10. Gastroesophageal Reflux Disease Devices Market, by Dosage Form

  • 10.1. Introduction
  • 10.2. Liquid
  • 10.3. Solid

11. Gastroesophageal Reflux Disease Devices Market, by Route of Administration

  • 11.1. Introduction
  • 11.2. Oral
  • 11.3. Parenteral

12. Gastroesophageal Reflux Disease Devices Market, by End-User

  • 12.1. Introduction
  • 12.2. Government
  • 12.3. Hospitals
  • 12.4. Medical Practitioners

13. Americas Gastroesophageal Reflux Disease Devices Market

  • 13.1. Introduction
  • 13.2. Argentina
  • 13.3. Brazil
  • 13.4. Canada
  • 13.5. Mexico
  • 13.6. United States

14. Asia-Pacific Gastroesophageal Reflux Disease Devices Market

  • 14.1. Introduction
  • 14.2. Australia
  • 14.3. China
  • 14.4. India
  • 14.5. Indonesia
  • 14.6. Japan
  • 14.7. Malaysia
  • 14.8. Philippines
  • 14.9. Singapore
  • 14.10. South Korea
  • 14.11. Taiwan
  • 14.12. Thailand
  • 14.13. Vietnam

15. Europe, Middle East & Africa Gastroesophageal Reflux Disease Devices Market

  • 15.1. Introduction
  • 15.2. Denmark
  • 15.3. Egypt
  • 15.4. Finland
  • 15.5. France
  • 15.6. Germany
  • 15.7. Israel
  • 15.8. Italy
  • 15.9. Netherlands
  • 15.10. Nigeria
  • 15.11. Norway
  • 15.12. Poland
  • 15.13. Qatar
  • 15.14. Russia
  • 15.15. Saudi Arabia
  • 15.16. South Africa
  • 15.17. Spain
  • 15.18. Sweden
  • 15.19. Switzerland
  • 15.20. Turkey
  • 15.21. United Arab Emirates
  • 15.22. United Kingdom

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2023
  • 16.2. FPNV Positioning Matrix, 2023
  • 16.3. Competitive Scenario Analysis
  • 16.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Addex Pharmaceuticals Ltd.
  • 2. Aros Pharma ApS
  • 3. AstraZeneca PLC
  • 4. C. R. Bard, Inc.
  • 5. Eisai Co., Ltd.
  • 6. EndoGastric Solutions, Inc.
  • 7. Frost & Sullivan Inc.
  • 8. Johnson & Johnson Services, Inc.
  • 9. KARL STORZ SE & Co. KG
  • 10. MediGus Ltd.
  • 11. Olympus Corporation
  • 12. PENTAX Europe GmbH
  • 13. Pfizer Inc.
  • 14. Takeda Pharmaceutical Company Limited
  • 15. The Procter & Gamble Company

LIST OF FIGURES

  • FIGURE 1. GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 19. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 23. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 27. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 28. GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 29. GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ESOPHAGOSCOPES & GASTROSCOPES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY FUNDOPLICATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MANOMETRY SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PH MONITORING SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPHINCTER AUGMENTATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ULTRASONIC SURGICAL ENDOSTAPLER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY FUNDOPLICATION PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY THERMAL ABLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY LINX REFLUX MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MEDIGUS ULTRASONIC SURGICAL ENDOSTAPLER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOCINCH ENDOLUMMINAL GASTROPLICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC PLICATOR SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ESOPHYX, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PLEXIGLAS POLY-METHYL-METHACRYLATE MICROSPHERES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY STRETTA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY BRAVO REFLUX TESTING SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DIGITRAPPER REFLUX TESTING SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY LINX MANAGEMENT SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MUSE -MEDIGUS ULTRASONIC SURGICAL ENDOSTAPLER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY STRETTA THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SOLID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GOVERNMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MEDICAL PRACTITIONERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. ARGENTINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 65. ARGENTINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. ARGENTINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 67. ARGENTINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 68. ARGENTINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. BRAZIL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. BRAZIL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. BRAZIL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 73. BRAZIL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 74. BRAZIL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. BRAZIL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 76. BRAZIL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 77. BRAZIL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. CANADA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. CANADA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. CANADA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. CANADA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 82. CANADA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 83. CANADA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. CANADA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 85. CANADA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 86. CANADA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. MEXICO GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. MEXICO GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. MEXICO GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. MEXICO GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 91. MEXICO GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 92. MEXICO GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. MEXICO GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 94. MEXICO GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 95. MEXICO GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 116. AUSTRALIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. AUSTRALIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. AUSTRALIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. AUSTRALIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 120. AUSTRALIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 121. AUSTRALIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. AUSTRALIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 123. AUSTRALIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 124. AUSTRALIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. CHINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. CHINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. CHINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. CHINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 129. CHINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 130. CHINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. CHINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 132. CHINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 133. CHINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. INDIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. INDIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. INDIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. INDIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 138. INDIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 139. INDIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. INDIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 141. INDIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 142. INDIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. INDONESIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. INDONESIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. INDONESIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. INDONESIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 147. INDONESIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 148. INDONESIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. INDONESIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 150. INDONESIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 151. INDONESIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. JAPAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. JAPAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. JAPAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. JAPAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 156. JAPAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 157. JAPAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. JAPAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 159. JAPAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 160. JAPAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. MALAYSIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. MALAYSIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. MALAYSIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. MALAYSIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 165. MALAYSIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 166. MALAYSIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. MALAYSIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 168. MALAYSIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 169. MALAYSIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. PHILIPPINES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. PHILIPPINES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. PHILIPPINES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. PHILIPPINES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 174. PHILIPPINES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 175. PHILIPPINES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. PHILIPPINES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 177. PHILIPPINES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 178. PHILIPPINES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. SINGAPORE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. SINGAPORE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. SINGAPORE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. SINGAPORE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 183. SINGAPORE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 184. SINGAPORE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. SINGAPORE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 186. SINGAPORE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 187. SINGAPORE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. SOUTH KOREA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. SOUTH KOREA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. SOUTH KOREA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. SOUTH KOREA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 192. SOUTH KOREA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 193. SOUTH KOREA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. SOUTH KOREA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 195. SOUTH KOREA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 196. SOUTH KOREA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. TAIWAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. TAIWAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. TAIWAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. TAIWAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 201. TAIWAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 202. TAIWAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. TAIWAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 204. TAIWAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 205. TAIWAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. THAILAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. THAILAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. THAILAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. THAILAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 210. THAILAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 211. THAILAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. THAILAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 213. THAILAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 214. THAILAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 215. VIETNAM GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. VIETNAM GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. VIETNAM GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. VIETNAM GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 219. VIETNAM GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 220. VIETNAM GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. VIETNAM GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 222. VIETNAM GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 223. VIETNAM GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 234. DENMARK GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. DENMARK GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. DENMARK GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. DENMARK GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 238. DENMARK GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 239. DENMARK GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 240. DENMARK GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 241. DENMARK GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 242. DENMARK GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 243. EGYPT GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 244. EGYPT GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 245. EGYPT GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. EGYPT GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 247. EGYPT GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 248. EGYPT GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. EGYPT GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 250. EGYPT GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 251. EGYPT GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 252. FINLAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 253. FINLAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. FINLAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 255. FINLAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 256. FINLAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 257. FINLAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 258. FINLAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 259. FINLAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 260. FINLAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 261. FRANCE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 262. FRANCE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 263. FRANCE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 264. FRANCE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 265. FRANCE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 266. FRANCE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. FRANCE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 268. FRANCE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 269. FRANCE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 270. GERMANY GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 271. GERMANY GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 272. GERMANY GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 273. GERMANY GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 274. GERMANY GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 275. GERMANY GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 276. GERMANY GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 277. GERMANY GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 278. GERMANY GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 279. ISRAEL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 280. ISRAEL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 281. ISRAEL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 282. ISRAEL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 283. ISRAEL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE,